217 related articles for article (PubMed ID: 31082865)
1. Off-Label Use of Clozapine in Children and Adolescents-A Literature Review.
Rachamallu V; Elberson BW; Vutam E; Aligeti M
Am J Ther; 2019; 26(3):e406-e416. PubMed ID: 31082865
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.
Kranzler HN; Cohen SD
Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
[TBL] [Abstract][Full Text] [Related]
5. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. Long-term sustained benefits of clozapine treatment in refractory early onset schizophrenia: a retrospective study in Korean children and adolescents.
Kim Y; Kim BN; Cho SC; Kim JW; Shin MS
Hum Psychopharmacol; 2008 Dec; 23(8):715-22. PubMed ID: 18814190
[TBL] [Abstract][Full Text] [Related]
8. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland.
Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H
Lancet Psychiatry; 2024 Jun; 11(6):443-450. PubMed ID: 38697177
[TBL] [Abstract][Full Text] [Related]
9. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
10. Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach.
Glick ID; Correll CU; Altamura AC; Marder SR; Csernansky JG; Weiden PJ; Leucht S; Davis JM
J Clin Psychiatry; 2011 Dec; 72(12):1616-27. PubMed ID: 22244023
[TBL] [Abstract][Full Text] [Related]
11. Clozapine: balancing safety with superior antipsychotic efficacy.
Meltzer HY
Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):134-44. PubMed ID: 23006238
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
13. Clozapine for Management of Childhood and Adolescent-Onset Schizophrenia: A Systematic Review and Meta-Analysis.
Adnan M; Motiwala F; Trivedi C; Sultana T; Mansuri Z; Jain S
J Child Adolesc Psychopharmacol; 2022 Feb; 32(1):2-11. PubMed ID: 35099269
[No Abstract] [Full Text] [Related]
14. CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.
Casetta C; Santosh P; Bayley R; Bisson J; Byford S; Dixon C; Drake RJ; Elvins R; Emsley R; Fung N; Hayes D; Howes O; James A; James K; Jones R; Killaspy H; Lennox B; Marchant L; McGuire P; Oloyede E; Rogdaki M; Upthegrove R; Walters J; Egerton A; MacCabe JH
BMC Psychiatry; 2024 Feb; 24(1):122. PubMed ID: 38355533
[TBL] [Abstract][Full Text] [Related]
15. Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
Wagner E; Kane JM; Correll CU; Howes O; Siskind D; Honer WG; Lee J; Falkai P; Schneider-Axmann T; Hasan A;
Schizophr Bull; 2020 Dec; 46(6):1459-1470. PubMed ID: 32421188
[TBL] [Abstract][Full Text] [Related]
16. Clozapine use in children and adolescents.
Gogtay N; Rapoport J
Expert Opin Pharmacother; 2008 Feb; 9(3):459-65. PubMed ID: 18220495
[TBL] [Abstract][Full Text] [Related]
17. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
Jiménez-Cornejo M; Munizaga G; Aceituno D
Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
[TBL] [Abstract][Full Text] [Related]
18. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
20. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
